test

Developmental Therapeutics

Harriet Kluger MD

Associate Professor of Medicine (Medical Oncology); Associate Director, Hematology/Oncology Fellowship Program

Biographical Info

Dr. Kluger is a medical oncologist who sees patients with melanoma, renal cell carcinoma and breast cancer. Her research interests focus on developing new drugs and biomarkers predictive of response to these drugs in melanoma and renal cell carcinoma. She participates in a number of clinical trials studying new agents for the treatment of these diseases, both targeting the immune system and the cancer cell. She runs and active research laboratory that studies tumors and cells from patients treated with novel therapies.


Education & Training

M.D.
Tel Aviv University (1993)
Resident
Highland General Hospital, Internal Medicine (1995 - 1996)
Resident
University of New Mexico, Internal Medicine (1993 - 1995)
Fellow
Yale University School of Medicine, Hematology/Medical Oncology (1999 - 2002)
Board Certification
Hematology (Internal Medicine), Board Eligible 
Board Certification
Medical Oncology, Board Certified  (2002)

Edit Profile